Nalaganje...
Naftidrofuryl for intermittent claudication
BACKGROUND: Lifestyle changes and cardiovascular prevention measures are a primary treatment for intermittent claudication (IC). Symptomatic treatment with vasoactive agents (Anatomic Therapeutic Chemical Classification (ATC) for medicines from the World Health Organisation class CO4A) is controvers...
Shranjeno v:
| izdano v: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2012
|
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7075104/ https://ncbi.nlm.nih.gov/pubmed/23235580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001368.pub4 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|